x

Search for a clinical trial

* (*) mandatory field

WAS FUP : Long Term Safety Follow up of Patients Enrolled in the Phase I/II Clinical Trial of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome (GTG002-07 and GTG003-08) - FR

  • Type of clinical trial : Gene therapy clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • AFM (ASSOCIATION FRANÇAISE CONTRE LES MYOPATHIES)
  • Geographic coverage : European
  • Sponsor : Genethon
  • Website
    • Phase : I - II
  • Principal investigator of clinical trial

  • Pr Marina CAVAZZANA
  • Département de Biothérapie - Unité d'Hémaphérèse Thérapeutique
  • Hôpital Necker-Enfants Malades
  • 149 rue de Sèvres
  • 75743 PARIS
  • FRANCE
  • More information
  • Phone  : 33 (0)1 44 49 52 74
  • Fax  : 33 (0)1 44 49 52 76
  • Website
  • Sponsor of clinical trial

  • GENETHON
  • Centre de Recherche Généthon
  • Institut des Biothérapies
  • Généthon
  • 1 bis rue de l'Internationale
  • 91000 EVRY CEDEX
  • FRANCE
  • More information
  • Phone  : 33 (0) 1 69 47 28 28
  • Fax  : -
  • Website
Last update: October 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.